Literature DB >> 15711245

Is benign prostatic hyperplasia a risk factor for chronic renal failure?

Andrew D Rule1, Michael M Lieber, Steven J Jacobsen.   

Abstract

PURPOSE: Benign prostatic hyperplasia (BPH) and chronic renal failure (CRF) are common medical conditions in older men. Based on the low prevalence of CRF in clinical trials recent American Urological Association guidelines have not recommended routine serum creatinine screening in men presenting with lower urinary tract symptoms. However, chronic renal failure is a well described complication of obstructive BPH.
MATERIALS AND METHODS: A structured MEDLINE review of the literature on the association between BPH and CRF from 1966 to 2003 was performed.
RESULTS: Most studies were referral based and did not represent the full spectrum of BPH in men. The definition of renal failure varied from a serum creatinine cutoff of 1.5 to 3.0 mg/dl. Differentiating acute and chronic renal failure, and acute and chronic urinary retention was often not done. Various combinations of chronic retention with large residual urine volumes (greater than 300 ml), detrusor instability and decreased bladder compliance were associated with chronic renal failure. Ureterovesicular junction obstruction from bladder remodeling in chronic urinary retention was the most commonly proposed mechanism for CRF. However, episodic acute urinary retention, urinary tract infections and secondary hypertension may also have a role. Studies showed significant improvement in renal function after prostate surgery but the acuity of renal failure was generally not known.
CONCLUSIONS: The extent of the association between BPH and CRF is unknown and more community based, observational studies are needed. However, an association exists and it should be considered in men presenting with obstructive BPH or CRF.

Entities:  

Mesh:

Year:  2005        PMID: 15711245     DOI: 10.1097/01.ju.0000153518.11501.d2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

1.  [Diagnostic and differential diagnosis of benign prostate syndrome (BPS): guidelines of the German Urologists].

Authors:  R Berges; K Dreikorn; K Höfner; S Madersbacher; M C Michel; R Muschter; M Oelke; O Reich; W Rulf; C Tschuschke; U Tunn
Journal:  Urologe A       Date:  2009-11       Impact factor: 0.639

Review 2.  [Diagnostics of benign prostate syndrome].

Authors:  M Seitz; A Herlemann; G Magistro; C G Stief
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

3.  The Advantages of Transurethral Resection of the Prostate in Patients with an Elevated or Rising Prostate Specific Antigen, Mild or Moderate Lower Urinary Tract Symptoms, Bladder Outlet Obstruction and Negative Prostate Cancer Imaging or Prostate Biopsies: A Prospective Analysis in 105 Consecutive Patients.

Authors:  Evert Baten; Koenraad van Renterghem
Journal:  Curr Urol       Date:  2017-07-30

4.  Transurethral prostate surgery as a preventive method against progression of chronic kidney disease in patients with urodynamically proven bladder outlet obstruction.

Authors:  Dong Sup Lee; Hyung Wook Kim; Seung-Ju Lee
Journal:  World J Urol       Date:  2019-12-04       Impact factor: 4.226

5.  Incidence, predictors, and associated outcomes of prostatism after kidney transplantation.

Authors:  Frank P Hurst; Robert T Neff; Edward M Falta; Rahul M Jindal; Krista L Lentine; John S Swanson; Lawrence Y Agodoa; Kevin C Abbott
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 8.237

6.  Perirenal fat stranding on CT: is there an association with bladder outlet obstruction?

Authors:  Na Y Han; Deuk J Sung; Min J Kim; Beom J Park; Ki C Sim; Sung B Cho
Journal:  Br J Radiol       Date:  2016-04-28       Impact factor: 3.039

7.  Need for quality improvement in renal systematic reviews.

Authors:  Marko Mrkobrada; Heather Thiessen-Philbrook; R Brian Haynes; Arthur V Iansavichus; Faisal Rehman; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 8.237

8.  Should an antimuscarinic agent be used for persistent LUTS after treatment with an alpha(1)-blocker?

Authors:  Yukio Homma
Journal:  Nat Clin Pract Urol       Date:  2008-12-23

9.  Lack of disparity in lower urinary tract symptom severity between community-dwelling non-Hispanic white, Mexican-American, and African-American men.

Authors:  Alayne D Markland; Ian M Thompson; Donna P Ankerst; Betsy Higgins; Stephen R Kraus
Journal:  Urology       Date:  2007-04       Impact factor: 2.649

Review 10.  A new algorithm in patients with elevated and/or rising prostate-specific antigen level, minor lower urinary tract symptoms, and negative multisite prostate biopsies.

Authors:  Koenraad van Renterghem; Gommert Van Koeveringe; Ruth Achten; Philip van Kerrebroeck
Journal:  Int Urol Nephrol       Date:  2009-06-03       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.